Results 11 to 20 of about 1,701,551 (356)
Journal of the American College of Surgeons, 2000 The history of solid organ transplantation is traced from its beginnings in the 19th century to the beginning of the 21st century. Surgical techniques, advances in immunology, and a review of major immunosuppressive milestones are reviewed. Over the last 50 years, transplantation has moved from experimental to accepted clinical therapy.
M, Davies, A, Hollman
+8 more sources
Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study). [PDF]
, 2020 IMPORTANCE Skin cancer, in particular squamous cell carcinoma, is the most frequent malignancy among solid organ transplant recipients with a higher incidence compared to the general population.
Hunger, R.E. +27 more
core +1 more source
A scoping review of inequities in access to organ transplant in the United States
International Journal for Equity in Health, 2022 Background Organ transplant is the preferred treatment for end-stage organ disease, yet the majority of patients with end-stage organ disease are never placed on the transplant waiting list. Limited access to the transplant waiting list combined with the
Christi Park +6 more
semanticscholar +1 more source
To Transplant or Not to Transplant – That Is the Question [PDF]
, 2010 Thousands of human ovaries have been stored for desperate cancer patients by practitioners around the world. Unfortunately, most of these ovaries were stored without a clear idea about how they could be used by the eventual survivor. Recent advances in ovarian tissue freezing and transplant technology and in the emerging area of in vitro follicle ...
Sherman J, Silber +2 more
openaire +2 more sources
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter
American Journal of Transplantation, 2020 Solid organ transplant recipients may be at a high risk for SARS‐CoV‐2 infection and poor associated outcomes. We herein report our initial experience with solid organ transplant recipients with SARS‐CoV‐2 infection at two centers during the first 3 ...
Marcus R. Pereira +25 more
semanticscholar +1 more source
Case Reports in Oncology, 2022 Venetoclax (VEN) is an oral B-cell lymphoma-2 (BCL-2) inhibitor that has been widely used to treat various hematological disorders. Recent studies have demonstrated that VEN in combination with fludarabine-enhanced high-dose cytarabine (FLA) is effective
Hiroyuki Murakami +13 more
doaj +1 more source
Horticulturae, 2022 We evaluated the effect of water and ethephon (2-chloroethyl phosphonic acid) under different doses (500 mg·L−1, 1000 mg·L−1,2000 mg·L−1, and 3000 mg·L−1), with and without calcium acetate (CA) in two foliar applications on camphor and golden shower ...
Nelson Li, Kuo-Chin Lo, Yu-Sen Chang
doaj +1 more source
, 2023 Background and Objectives: Community-acquired respiratory virus (CARV) infections pose a serious risk for lung transplant recipients (LTR) as they are prone to severe complications.
The Swiss Transplant Cohort Study +11 more
core +1 more source
Journal of Medical Ethics, 1968 In this paper Professor Calne pleads for a more informed approach to the problem of donor transplants, particularly in cases of kidney disease. He is concerned to inform both the medical profession and lay people. Establishing a computerized register of names and addresses of those who do not wish to have their organs used for transplantation after ...
openaire +5 more sources
COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium
American Journal of Transplantation, 2020 Kidney transplant recipients may be at a high risk of developing critical coronavirus disease 2019 (COVID‐19) illness due to chronic immunosuppression and comorbidities.
P. Cravedi +23 more
semanticscholar +1 more source